 |
N-[4-(trifluoromethyl)phenyl] 5 methylisoxazole-4-carboxamide |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 1995-05-25 00:00:00 |
| Sponsor | Sugen, Inc.;230 East Grand Ave.;South San Francisco, California, 94080 |
Related Access Program